TNFRSF17 and Miyoshi myopathy: The expression of BCMA on MM cells is subject to variation, as evidenced by the emergence of BCMA-negative relapses and the presence of MM cells expressing low levels of BCMA prior to anti-BCMA therapy [25,70].